glp-1 agonist fda approval Market Overview: Agonists and the Obesity Market | Blog GLP-1 RAs gain popularity as
Description
The result: reduced risk for depression and improved mental health
Playdon MC, Bracken MB, Sanft TB, Ligibel JA, Harrigan M, Irwin ML
nutrition helps the body adapt and recover
CI 0.4 to 0.2%
Body Mass Index as a Phenotypic Expression of Adiposity: Quantitative Contribution of Muscularity in a Population-Based Sample
However, anaesthetists must take into account the theoretical increased risk of aspiration in patients taking GLP-1 agonists, as presented by the aforementioned case reports
